Envoy Medical, Inc.
COCH
$1.12
-$0.03-2.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.91% | 14.89% | 30.50% | 42.27% | 65.31% |
| Total Depreciation and Amortization | 58.82% | 42.86% | 30.08% | 55.86% | 47.12% |
| Total Amortization of Deferred Charges | 34.97% | 79.24% | 163.46% | -- | -- |
| Total Other Non-Cash Items | 160.80% | -82.67% | -81.41% | -90.50% | -118.46% |
| Change in Net Operating Assets | 137.33% | 144.59% | 15.97% | -204.99% | -418.12% |
| Cash from Operations | 24.17% | 20.86% | -1.98% | -190.53% | -70.40% |
| Capital Expenditure | 35.85% | -599.01% | -894.77% | -1,100.58% | -425.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 91.04% | -332.02% | -540.52% | -787.28% | -425.13% |
| Total Debt Issued | 114.29% | 81.82% | 100.00% | 25.00% | -12.50% |
| Total Debt Repaid | -28.00% | -72.07% | -154.88% | -- | -- |
| Issuance of Common Stock | -60.10% | -75.78% | 1,842.20% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -84.53% | -84.53% | -84.53% | -100.00% | 12,656.52% |
| Cash from Financing | -17.17% | -29.11% | -7.53% | -46.19% | 89.76% |
| Foreign Exchange rate Adjustments | 120.00% | 140.00% | -66.67% | 28.57% | 28.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.03% | -90.42% | -68.65% | -176.50% | 42,050.00% |